Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-19 Sale |
2025-03-20 9:01 pm |
Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
5,784,292 | $2.0742 | $11,997,749 | 2,733,547 (Direct) |
View |
2024-11-14 Sale |
2024-11-18 9:12 pm |
Molecular Templates Inc. | MTEM | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
1,279,820 | $0.6609 | $845,833 | 904,001 (Direct) |
View |
2024-11-01 Sale |
2024-11-05 12:06 pm |
ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
7,879,583 | $1.5253 | $12,018,409 | 0 (Direct) |
View |
2024-04-02 Purchase |
2024-04-04 8:13 pm |
Molecular Templates Inc. | MTEM | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
250,000 | $2.35 | $587,500 | 2,183,821 (Direct) |
View |
2023-10-17 Purchase |
2023-10-19 3:08 pm |
Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
400,000 | $2.3352 | $934,080 | 8,517,839 (Direct) |
View |
2023-10-02 Purchase |
2023-10-04 3:31 pm |
MACROGENICS INC | MGNX | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
150,000 | $4.4639 | $669,585 | 9,929,963 (Direct) |
View |
2023-09-07 Purchase |
2023-09-11 3:39 pm |
MACROGENICS INC | MGNX | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
200,000 | $5.2642 | $1,052,840 | 9,779,963 (Direct) |
View |
2023-07-17 Purchase |
2023-07-19 3:14 pm |
Molecular Templates Inc. | MTEM | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
4,255,319 | $0.47 | $2,000,000 | 15,447,322 (Direct) |
View |
2023-06-30 Purchase |
2023-07-03 3:36 pm |
Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
1,000,000 | $5 | $5,000,000 | 8,117,839 (Direct) |
View |
2023-06-27 Purchase |
2023-06-29 1:37 pm |
Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
1,740,000 | $5.4914 | $9,555,036 | 7,117,839 (Direct) |
View |
2023-02-14 Purchase |
2023-02-16 12:37 pm |
MACROGENICS INC | MGNX | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
500,000 | $5.0652 | $2,532,600 | 9,579,963 (Direct) |
View |
2023-01-19 Purchase |
2023-01-23 4:21 pm |
MACROGENICS INC | MGNX | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
150,000 | $5.2995 | $794,925 | 9,079,963 (Direct) |
View |
2022-12-23 Purchase |
2022-12-28 11:03 am |
MACROGENICS INC | MGNX | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
400,000 | $5.7465 | $2,298,600 | 8,929,963 (Direct) |
View |
2022-11-22 Purchase |
2022-11-25 11:37 am |
MACROGENICS INC | MGNX | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
300,000 | $5.9606 | $1,788,180 | 8,529,963 (Direct) |
View |
2022-10-31 Purchase |
2022-11-02 3:10 pm |
Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
99,801 | $2.2536 | $224,912 | 5,377,839 (Direct) |
View |
2022-10-27 Purchase |
2022-10-31 3:20 pm |
Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
364,652 | $2.0189 | $736,186 | 5,278,038 (Direct) |
View |
2022-10-26 Purchase |
2022-10-28 2:57 pm |
ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
2,000,000 | $4.1098 | $8,219,600 | 7,879,583 (Direct) |
View |
2022-10-21 Purchase |
2022-10-25 4:24 pm |
Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
87,850 | $1.5111 | $132,750 | 4,913,386 (Direct) |
View |
2022-10-21 Purchase |
2022-10-25 4:19 pm |
MACROGENICS INC | MGNX | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
500,000 | $4.4952 | $2,247,600 | 8,229,963 (Direct) |
View |
2022-10-19 Purchase |
2022-10-21 3:06 pm |
Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
131,423 | $1.3629 | $179,120 | 4,825,536 (Direct) |
View |
2022-10-19 Purchase |
2022-10-21 3:03 pm |
MACROGENICS INC | MGNX | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
454,399 | $3.8897 | $1,767,484 | 7,729,963 (Direct) |
View |
2022-07-18 Purchase |
2022-07-20 3:21 pm |
ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
300,000 | $3.1558 | $946,740 | 5,879,583 (Direct) |
View |
2022-07-14 Purchase |
2022-07-18 12:48 pm |
ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
588,869 | $2.9314 | $1,726,226 | 5,579,583 (Direct) |
View |
2022-05-18 Purchase |
2022-05-20 11:35 am |
Radius Health Inc. | RDUS | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
477,824 | $5.569 | $2,661,002 | 8,733,538 (Direct) |
View |
2022-05-16 Purchase |
2022-05-18 12:21 pm |
Molecular Templates Inc. | MTEM | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
200,000 | $1.181 | $236,200 | 11,192,003 (Direct) |
View |
2022-04-27 Purchase |
2022-04-29 10:50 am |
Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
405,711 | $2.6062 | $1,057,348 | 4,694,113 (Direct) |
View |
2022-04-27 Sale |
2022-04-28 12:28 pm |
ESSA Pharma Inc. | EPIX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
25,100 | $5.8536 | $146,925 | 4,990,714 (Direct) |
View |
2022-04-18 Purchase |
2022-04-20 12:56 pm |
Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
300,000 | $3.2686 | $980,580 | 4,288,402 (Direct) |
View |
2022-04-12 Purchase |
2022-04-14 12:09 pm |
Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
252,556 | $3.4837 | $879,817 | 3,988,402 (Direct) |
View |
2022-01-06 Purchase |
2022-01-10 11:49 am |
Molecular Templates Inc. | MTEM | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
200,000 | $4.0359 | $807,180 | 10,992,003 (Direct) |
View |
2022-01-05 Purchase |
2022-01-07 11:33 am |
Radius Health Inc. | RDUS | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
550,000 | $6.3074 | $3,469,060 | 8,255,714 (Direct) |
View |
2021-11-19 Purchase |
2021-11-23 12:29 pm |
MACROGENICS INC | MGNX | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
200,000 | $18.5 | $3,700,320 | 7,275,564 (Direct) |
View |
2021-09-29 Purchase |
2021-10-01 10:34 am |
Radius Health Inc. | RDUS | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
100,000 | $12.95 | $1,294,500 | 7,705,714 (Direct) |
View |
2021-09-28 Purchase |
2021-09-30 3:09 pm |
MACROGENICS INC | MGNX | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
200,000 | $20.56 | $4,111,420 | 7,075,564 (Direct) |
View |
2021-09-22 Purchase |
2021-09-24 11:58 am |
Radius Health Inc. | RDUS | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
150,000 | $12.28 | $1,841,280 | 7,605,714 (Direct) |
View |
2021-09-21 Purchase |
2021-09-23 11:50 am |
Molecular Templates Inc. | MTEM | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
750,000 | $6 | $4,500,000 | 10,792,003 (Direct) |
View |
2021-09-16 Purchase |
2021-09-20 12:21 pm |
MACROGENICS INC | MGNX | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
600,000 | $20.61 | $12,363,480 | 6,875,564 (Direct) |
View |
2021-09-16 Purchase |
2021-09-20 12:17 pm |
Molecular Templates Inc. | MTEM | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
100,000 | $6.13 | $613,000 | 10,042,003 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-08-11 Equity Swap |
2022-08-30 12:05 pm |
N/A N/A |
Radius Health Inc. | RDUS | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
8,733,538 | $10 | 0 (Direct) |
View |
Ownership |
2022-04-13 4:22 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
0 | $0 | 3,735,846 (Direct) |
View |